{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:32:22Z","timestamp":1771356742454,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T00:00:00Z","timestamp":1335916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Clinical trials for alcoholism have historically regarded alcohol consumption as the primary outcome. In a subset of trials, quality of life (<jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content>) has been considered as a secondary outcome. Joint latent\u2010variable modeling techniques may provide a more accurate and powerful simultaneous analysis of primary and secondary outcomes in clinical trials. The goal of this study was to evaluate longitudinal associations between treatment status, alcohol consumption, and <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content> in the <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>ombined <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>harmacotherapies and <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>ehavioral <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>nterventions for <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>lcohol <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ependence (<jats:styled-content style=\"fixed-case\">COMBINE<\/jats:styled-content>) study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 1,383 alcohol\u2010dependent patients were randomized to 9 treatment groups. Percent heavy drinking days (<jats:styled-content style=\"fixed-case\">PHDD<\/jats:styled-content>) and health\u2010related <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content> from the 30\u00a0days preceding baseline, week 16, and week 52 were calculated using the <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>orm 90 and the <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>edical <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>utcomes <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>tudy <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>ealth <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>urvey <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>hort <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>orm\u201012 (<jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>\u201012), respectively. Latent profile analysis (<jats:styled-content style=\"fixed-case\">LPA<\/jats:styled-content>) was conducted to determine an appropriate number of latent states to represent <jats:styled-content style=\"fixed-case\">PHDD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content>. Subsequently, univariate and coupled hidden <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>arkov models (for <jats:styled-content style=\"fixed-case\">PHDD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>\u201012 mental health, and <jats:styled-content style=\"fixed-case\">PHDD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>\u201012 physical) were fit to the data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>\n<jats:styled-content style=\"fixed-case\">LPA<\/jats:styled-content> suggested that <jats:styled-content style=\"fixed-case\">PHDD<\/jats:styled-content> should be represented by 3 latent states and that each <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>\u201012 scale should be represented by 2 states. Joint modeling results suggested that (i) naltrexone significantly predicted decreased <jats:styled-content style=\"fixed-case\">PHDD<\/jats:styled-content> (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.05), and marginally predicted improved mental health <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content> via decreased <jats:styled-content style=\"fixed-case\">PHDD<\/jats:styled-content> (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.10), and (ii) that the combinations of naltrexone and combined behavioral intervention (<jats:styled-content style=\"fixed-case\">CBI<\/jats:styled-content>), and acamprosate and <jats:styled-content style=\"fixed-case\">CBI<\/jats:styled-content>, each predicted significantly improved physical <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content> (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.05), and marginally predicted decreased <jats:styled-content style=\"fixed-case\">PHDD<\/jats:styled-content> via improved physical <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content> (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.10).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study illustrates a powerful and novel statistical approach for simultaneously evaluating the impact of treatments on primary and secondary outcomes in clinical trials. This study also suggests that behavioral interventions may impact drinking behavior through their ameliorative effects on <jats:styled-content style=\"fixed-case\">QOL<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1530-0277.2012.01823.x","type":"journal-article","created":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T18:12:53Z","timestamp":1335982373000},"page":"2141-2149","source":"Crossref","is-referenced-by-count":6,"title":["Simultaneous Modeling of the Impact of Treatments on Alcohol Consumption and Quality of Life in the <scp>COMBINE<\/scp> Study: A Coupled Hidden Markov Analysis"],"prefix":"10.1111","volume":"36","author":[{"given":"James J.","family":"Prisciandaro","sequence":"first","affiliation":[{"name":"Clinical Neuroscience Division, Department of Psychiatry and Behavioral Sciences Medical University of South Carolina  Charleston South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacia M.","family":"DeSantis","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Epidemiology, Department of Medicine Medical University of South Carolina  Charleston South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipankar","family":"Bandyopadhyay","sequence":"additional","affiliation":[{"name":"Division of Biostatistics University of Minnesota School of Public Health  Minneapolis Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,5,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.17.2003"},{"key":"e_1_2_6_3_1","unstructured":"BrandM OliverN PentlandA(1997)Coupled Hidden Markov models for complex action recognition. Proceedings of IEEE Conference on Computer Vision and Pattern Recognition San Juan Puerto Rico June 17\u201319 994\u2013999."},{"key":"e_1_2_6_4_1","volume-title":"Measuring healthy days: population assessment of health\u2010related quality of life","author":"CDC","year":"2000"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/01.ALC.0000078020.92938.0B","article-title":"Testing combined pharmacotherapies and behavioral interventions in alcohol dependence (The COMBINE Study): a pilot feasibility study","volume":"27","author":"COMBINE Study Group","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4207"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.07.008"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsas.2005.s15.119"},{"key":"e_1_2_6_9_1","volume-title":"Structured Clinical Interview for DSM\u2010IV Axis I Disorders, Research Version. Patient Edition","author":"First M","year":"1996"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9280.2007.01882.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.10.017"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2011.00041"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2002.10613.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511499531.012"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/88.3.767"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2009.70.186"},{"key":"e_1_2_6_17_1","volume-title":"Hidden Markov and Other Methods for Discrete\u2010valued Time Series","author":"MacDonald IL","year":"1997"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsas.1994.s12.112"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000108652.73143.4B"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2003.tb00648.x"},{"key":"e_1_2_6_21_1","volume-title":"Mplus User's Guide","author":"Muthen LK","year":"2011"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2003.10.022"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2011.01645.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176344136"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02294360"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1214\/09-AOAS282"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3588"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.3928\/00485713-20090625-08"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.3758\/s13428-011-0076-x"},{"key":"e_1_2_6_30_1","volume-title":"SF\u201036\u00ae Health Survey & \u201cSF\u201d Bibliography: Third Edition (1988\u20132000)","author":"Turner\u2010Bowker DM","year":"2002"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3463"},{"key":"e_1_2_6_32_1","volume-title":"Quality of Life","author":"Ware JE","year":"1999"},{"key":"e_1_2_6_33_1","volume-title":"SF\u201036\u00ae Physical and Mental Health Summary Scales: A User's Manual","author":"Ware JE","year":"1994"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199603000-00003"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2010.01308.x"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2012.01823.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2012.01823.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T09:34:45Z","timestamp":1700559285000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2012.01823.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,2]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1530-0277.2012.01823.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2012.01823.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,2]]}}}